Search
Clobetasol propionate
go.drugbank.com/drugs/DB01013ApprovedInvestigational[L11815] It has demonstrated superior activity compared to [fluocinonide][A190963] and was first described in the literature in 1974.
Mixtures: FOLISTER COMPLEX HAIR LOTION (R), FOLISTER COMPLEX HAIR LOTION (R)Products: DERMOSOL CREAM 0.5 mg/g, CLONOVATE CREAM 0.05 g/100 gRubella virus vaccine
go.drugbank.com/drugs/DB10317ApprovedInvestigationalRubella virus vaccine is a live attenuated virus vaccine for active immunization against rubella (German measles) that is subcutaneously administered. It is prepared from RA 27/3 strain of live attenuated rubella virus. Rubella is a comm...
Mixtures: M-M-R II, M-M-R IIProducts: R-VAC 0,5 ML SC ENJ. COZ. ICIN LIY. TOZ ICEREN FLAKONCelivarone
go.drugbank.com/drugs/DB16012InvestigationalCelivarone is under investigation in clinical trial NCT00233441 (Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 Mg OD With Amiodarone as
Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
go.drugbank.com/drugs/DB10342ApprovedInvestigationalHaemophilus influenzae type b capsular polysaccharide meningococcal outer membrane protein conjugate antigen is a vaccine containing outer membrane antigen extracted from Haemophilus influenzae.
Mixtures: HEXAXIM 0.5 ML IM ENJEKSİYONLUK SÜSPANSİYON İÇEREN FLAKON, 1 ADET, HEXAXIM 0.5 ML IM ENJEKSİYONLUK SÜSPANSİYON İÇEREN FLAKON, 10 ADETProducts: HIBERIX 0,5 ML IM/SC ENJEKSIYON IÇIN LIYOFIHIZE TOZ IÇEREN FIAKON VE ÇÖZÜCÜ IÇEREN KULLANIMA HAZIR ENJEKTÖRSodium phosphate, dibasic
go.drugbank.com/drugs/DB14502ApprovedInvestigationalMixtures: SODIO FOSFATO MARCO VITI, Aminosyn II 8.5% M In 20% Dextrose (dual Chamber)Copper Deficiency
go.drugbank.com/conditions/DBCOND0048480Drugs: Cupric sulfateSynonyms: Copper low, Copper DeficiencyMobocertinib
go.drugbank.com/drugs/DB16390ApprovedInvestigationalWithdrawnIt is used specifically in the treatment of non-small cell lung cancer (NSCLC) caused by exon 20 insertion mutations in the _EGFR_ gene,[L38368] which are typically associated with a poorer prognosis ( … [A238828] Mobocertinib appears to be an effective means of treating this otherwise treatment-resistant NSCLC, exerting an inhibitory effect on _EGFR_ exon 20 insertion mutant variants at concentrations
Protamine
go.drugbank.com/drugs/DB13700ApprovedInvestigationalWithdrawnProducts: /ml - Injektionslösung, PROTAMYN 1000® UI/ML AMPOLLARoyal jelly
go.drugbank.com/drugs/DB14250InvestigationalRoyal jelly is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.
Mixtures: Vitasen C 100 with Royal Jelly Chewable TabletCategories: Complex MixturesPhenoxyethanol
go.drugbank.com/drugs/DB11304ApprovedInvestigationalAccording to the European Union Cosmetics Regulation (EC) n.1223/2009, phenoxyethanol is authorized as a preservative in cosmetic formulations at a maximum concentration of 1.0% [L2625].
Mixtures: Linola sept 1 mg/g + 20 mg/g Wund-Spray zur Anwendung auf der Haut, Lösung, OCTENISEPT ÇÖZELTI, 250 ML